Correlation Between Citigroup and Rossari Biotech

Can any of the company-specific risk be diversified away by investing in both Citigroup and Rossari Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Rossari Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Citigroup and Rossari Biotech Limited, you can compare the effects of market volatilities on Citigroup and Rossari Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Rossari Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Rossari Biotech.

Diversification Opportunities for Citigroup and Rossari Biotech

-0.51

Correlation Coefficient

Citigroup  Rossari Biotech

Excellent diversification

The 3 months correlation between Citigroup and Rossari is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Rossari Biotech Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rossari Biotech and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Rossari Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rossari Biotech has no effect on the direction of Citigroup i.e., Citigroup and Rossari Biotech go up and down completely randomly.

Pair Corralation between Citigroup and Rossari Biotech

Taking into account the 90-day investment horizon Citigroup is expected to generate 0.92 times more return on investment than Rossari Biotech. However, Citigroup is 1.09 times less risky than Rossari Biotech. It trades about 0.18 of its potential returns per unit of risk. Rossari Biotech Limited is currently generating about -0.07 per unit of risk. If you would invest  5,788  in Citigroup on September 16, 2024 and sell it today you would earn a total of  1,313  from holding Citigroup or generate 22.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.46%
Values	Daily Returns

Citigroup  vs.  Rossari Biotech Limited

Citigroup

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Citigroup exhibited solid returns over the last few months and may actually be approaching a breakup point.

Rossari Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rossari Biotech Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Pair Trading with Citigroup and Rossari Biotech

The main advantage of trading using opposite Citigroup and Rossari Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Rossari Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rossari Biotech will offset losses from the drop in Rossari Biotech's long position.

The idea behind Citigroup and Rossari Biotech Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..